$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Buy | X | 7.37 | 2,121 | 15,632 | 37,396 | 35.3 K to 37.4 K (+6.01 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Sell | S | 43.54 | 112,844 | 4,912,664 | 2,282,247 | 2.4 M to 2.3 M (-4.71 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Buy | X | 7.37 | 135,841 | 1,001,148 | 2,395,091 | 2.3 M to 2.4 M (+6.01 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Payment of Exercise | F | 48.60 | 8,999 | 437,351 | 38,347 | 47.3 K to 38.3 K (-19.01 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Buy | M | 34.99 | 12,500 | 437,375 | 47,346 | 34.8 K to 47.3 K (+35.87 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Payment of Exercise | F | 48.60 | 2,116 | 102,838 | 34,846 | 37 K to 34.8 K (-5.72 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Buy | M | 8.23 | 12,500 | 102,875 | 36,962 | 24.5 K to 37 K (+51.10 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Payment of Exercise | F | 48.60 | 1,302 | 63,277 | 24,462 | 25.8 K to 24.5 K (-5.05 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Buy | M | 6.33 | 10,000 | 63,300 | 25,764 | 15.8 K to 25.8 K (+63.44 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Payment of Exercise | F | 48.60 | 1,613 | 78,392 | 15,764 | 17.4 K to 15.8 K (-9.28 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Buy | M | 7.84 | 10,000 | 78,400 | 17,377 | 7.4 K to 17.4 K (+135.56 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Payment of Exercise | F | 48.60 | 2,623 | 127,478 | 7,377 | 10 K to 7.4 K (-26.23 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Buy | M | 12.75 | 10,000 | 127,500 | 10,000 | 0 to 10 K |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | M | 34.99 | 12,500 | 437,375 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | M | 8.23 | 12,500 | 102,875 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | M | 6.33 | 10,000 | 63,300 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | M | 7.84 | 10,000 | 78,400 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | M | 12.75 | 10,000 | 127,500 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Payment of Exercise | F | 48.60 | 8,999 | 437,351 | 38,347 | 47.3 K to 38.3 K (-19.01 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Buy | M | 34.99 | 12,500 | 437,375 | 47,346 | 34.8 K to 47.3 K (+35.87 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Payment of Exercise | F | 48.60 | 2,116 | 102,838 | 34,846 | 37 K to 34.8 K (-5.72 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Buy | M | 8.23 | 12,500 | 102,875 | 36,962 | 24.5 K to 37 K (+51.10 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Payment of Exercise | F | 48.60 | 1,302 | 63,277 | 24,462 | 25.8 K to 24.5 K (-5.05 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Buy | M | 6.33 | 10,000 | 63,300 | 25,764 | 15.8 K to 25.8 K (+63.44 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Payment of Exercise | F | 48.60 | 1,613 | 78,392 | 15,764 | 17.4 K to 15.8 K (-9.28 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Buy | M | 7.84 | 10,000 | 78,400 | 17,377 | 7.4 K to 17.4 K (+135.56 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Payment of Exercise | F | 48.60 | 2,623 | 127,478 | 7,377 | 10 K to 7.4 K (-26.23 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Buy | M | 12.75 | 10,000 | 127,500 | 10,000 | 0 to 10 K |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | M | 34.99 | 12,500 | 437,375 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | M | 8.23 | 12,500 | 102,875 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | M | 7.59 | 30,000 | 227,700 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Payment of Exercise | F | 48.60 | 8,999 | 437,351 | 39,200 | 48.2 K to 39.2 K (-18.67 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Buy | M | 34.99 | 12,500 | 437,375 | 48,199 | 35.7 K to 48.2 K (+35.01 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Payment of Exercise | F | 48.60 | 2,116 | 102,838 | 35,699 | 37.8 K to 35.7 K (-5.60 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Buy | M | 8.23 | 12,500 | 102,875 | 37,815 | 25.3 K to 37.8 K (+49.38 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Payment of Exercise | F | 48.60 | 4,685 | 227,691 | 25,315 | 30 K to 25.3 K (-15.62 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Buy | M | 7.59 | 30,000 | 227,700 | 30,000 | 0 to 30 K |
Dec 02 2011 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Buy | J | 25.13 | 206 | 5,177 | 206 | 0 to 206 |
Dec 02 2011 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Buy | J | 25.13 | 144 | 3,619 | 10,674 | 10.5 K to 10.7 K (+1.37 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | M | 7.84 | 10,000 | 78,400 | 0 | |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | M | 12.75 | 10,000 | 127,500 | 0 | |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | M | 18.00 | 17,500 | 315,000 | 0 | |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | M | 15.09 | 9,036 | 136,353 | 0 | |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Gift | G | 0.00 | 400 | 0 | 54,355 | 54.8 K to 54.4 K (-0.73 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Gift | G | 0.00 | 1,252 | 0 | 54,755 | 56 K to 54.8 K (-2.24 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Payment of Exercise | F | 34.99 | 2,240 | 78,378 | 56,007 | 58.2 K to 56 K (-3.85 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Buy | M | 7.84 | 10,000 | 78,400 | 58,247 | 48.2 K to 58.2 K (+20.73 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Payment of Exercise | F | 34.99 | 3,643 | 127,469 | 48,247 | 51.9 K to 48.2 K (-7.02 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Buy | M | 12.75 | 10,000 | 127,500 | 51,890 | 41.9 K to 51.9 K (+23.87 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Payment of Exercise | F | 34.99 | 9,002 | 314,980 | 41,890 | 50.9 K to 41.9 K (-17.69 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Buy | M | 18.00 | 17,500 | 315,000 | 50,892 | 33.4 K to 50.9 K (+52.41 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Payment of Exercise | F | 34.99 | 3,896 | 136,321 | 33,392 | 37.3 K to 33.4 K (-10.45 %) |
Dec 16 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Buy | M | 15.09 | 9,036 | 136,353 | 37,288 | 28.3 K to 37.3 K (+31.98 %) |
Dec 02 2011 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Buy | J | 6.43 | 2,363 | 15,194 | 3,428 | 1.1 K to 3.4 K (+221.88 %) |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | A | 0.00 | 751 | 0 | 9,643 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Dec 02 2011 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Buy | J | 14.89 | 1,007 | 14,994 | 1,215 | 208 to 1.2 K (+484.13 %) |
Dec 02 2011 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Buy | J | 25.13 | 596 | 14,977 | 289,011 | 288.4 K to 289 K (+0.21 %) |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Nov 14 2011 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Buy | P | 37.36 | 3,000 | 112,080 | 53,000 | 50 K to 53 K (+6.00 %) |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 0.00 | 608 | 0 | 4,691 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 0.00 | 786 | 0 | 22,249 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 0.00 | 715 | 0 | 9,929 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | MICHELSON MICHAEL W | Director | Option Exercise | A | 0.00 | 715 | 0 | 19,882 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | MICHELSON MICHAEL W | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 0.00 | 715 | 0 | 17,507 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | A | 0.00 | 715 | 0 | 16,079 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Nov 08 2011 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 34.99 | 12,500 | 437,375 | 12,500 | |
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR FINANCIAL HOLDINGS III, LL ... | Option Exercise | X | 9.34 | 70,156 | 655,257 | 0 | ||
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR FINANCIAL HOLDINGS III, LL ... | Sell | S | 36.04 | 53,964 | 1,945,046 | 0 | 54 K to 0 (-100.00 %) | |
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR FINANCIAL HOLDINGS III, LL ... | Sell | S | 40.47 | 16,192 | 655,290 | 53,964 | 70.2 K to 54 K (-23.08 %) | |
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR FINANCIAL HOLDINGS III, LL ... | Buy | X | 9.34 | 70,156 | 655,257 | 70,156 | 0 to 70.2 K | |
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR Group Holdings L.P. | 10% Owner | Option Exercise | X | 9.34 | 70,156 | 655,257 | 0 | |
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR Group Holdings L.P. | 10% Owner | Sell | S | 36.04 | 53,964 | 1,945,046 | 0 | 54 K to 0 (-100.00 %) |
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR Group Holdings L.P. | 10% Owner | Sell | S | 40.47 | 16,192 | 655,290 | 53,964 | 70.2 K to 54 K (-23.08 %) |
Sep 28 2011 | JAZZ | Jazz Pharmaceutica ... | KKR Group Holdings L.P. | 10% Owner | Buy | X | 9.34 | 70,156 | 655,257 | 70,156 | 0 to 70.2 K |
Aug 15 2011 | JAZZ | Jazz Pharmaceutica ... | Eller Mark G. | SVP, Research & Cli ... | Option Exercise | M | 0.00 | 690 | 0 | 0 | |
Aug 15 2011 | JAZZ | Jazz Pharmaceutica ... | Eller Mark G. | SVP, Research & Cli ... | Buy | M | 0.00 | 690 | 0 | 4,151 | 3.5 K to 4.2 K (+19.94 %) |
Aug 15 2011 | JAZZ | Jazz Pharmaceutica ... | DesJardin Michael A. | SVP, Product Develo ... | Option Exercise | M | 0.00 | 709 | 0 | 0 | |
Aug 15 2011 | JAZZ | Jazz Pharmaceutica ... | DesJardin Michael A. | SVP, Product Develo ... | Buy | M | 0.00 | 709 | 0 | 14,574 | 13.9 K to 14.6 K (+5.11 %) |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | Eller Mark G. | SVP, Research & Cli ... | Buy | J | 0.85 | 3,461 | 2,942 | 3,461 | 0 to 3.5 K |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Buy | J | 6.43 | 479 | 3,080 | 1,065 | 586 to 1.1 K (+81.74 %) |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Buy | J | 0.85 | 3,640 | 3,094 | 288,415 | 284.8 K to 288.4 K (+1.28 %) |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | DesJardin Michael A. | SVP, Product Develo ... | Buy | J | 0.85 | 3,494 | 2,970 | 13,865 | 10.4 K to 13.9 K (+33.69 %) |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Buy | J | 0.85 | 3,326 | 2,827 | 10,530 | 7.2 K to 10.5 K (+46.17 %) |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Buy | J | 0.85 | 1,323 | 1,125 | 48,544 | 47.2 K to 48.5 K (+2.80 %) |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Buy | J | 14.89 | 208 | 3,097 | 208 | 0 to 208 |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 0.00 | 911 | 0 | 9,214 | |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 0.00 | 1,002 | 0 | 21,463 | |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | A | 0.00 | 956 | 0 | 8,892 | |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 0.00 | 774 | 0 | 4,083 | |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | A | 0.00 | 911 | 0 | 15,364 | |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 0.00 | 911 | 0 | 16,792 | |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | Zilkha Nathaniel M | Director | Option Exercise | A | 0.00 | 637 | 0 | 13,498 | |
Mar 14 2011 | JAZZ | Jazz Pharmaceutica ... | MICHELSON MICHAEL W | Director | Option Exercise | A | 0.00 | 911 | 0 | 19,167 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP of Finance & PAO | Option Exercise | A | 27.46 | 50,000 | 1,373,000 | 50,000 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | Eller Mark G. | SVP, Research & Cli ... | Option Exercise | A | 27.46 | 30,000 | 823,800 | 30,000 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | DesJardin Michael A. | SVP, Product Develo ... | Option Exercise | A | 27.46 | 30,000 | 823,800 | 30,000 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Option Exercise | A | 27.46 | 40,000 | 1,098,400 | 40,000 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Option Exercise | A | 27.46 | 35,000 | 961,100 | 35,000 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | A | 27.46 | 35,000 | 961,100 | 35,000 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Option Exercise | A | 27.46 | 40,000 | 1,098,400 | 40,000 | |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 27.46 | 140,000 | 3,844,400 | 140,000 | |
Dec 08 2010 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Sell | S | 18.38 | 59,500 | 1,093,610 | 47,221 | 106.7 K to 47.2 K (-55.75 %) |
Dec 08 2010 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Sell | S | 18.75 | 500 | 9,375 | 106,721 | 107.2 K to 106.7 K (-0.47 %) |
Dec 02 2010 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Buy | J | 6.43 | 586 | 3,768 | 586 | 0 to 586 |
Dec 03 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | M | 7.96 | 16,115 | 128,275 | 28,885 | |
Dec 03 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | M | 1.25 | 8,885 | 11,106 | 31,115 | |
Dec 03 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Sell | S | 17.77 | 25,000 | 444,250 | 7,204 | 32.2 K to 7.2 K (-77.63 %) |
Dec 03 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Buy | M | 7.96 | 16,115 | 128,275 | 32,204 | 16.1 K to 32.2 K (+100.16 %) |
Dec 03 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Buy | M | 1.25 | 8,885 | 11,106 | 16,089 | 7.2 K to 16.1 K (+123.33 %) |
Dec 02 2010 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Buy | J | 0.85 | 1,391 | 1,182 | 107,221 | 105.8 K to 107.2 K (+1.31 %) |
Dec 02 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Buy | J | 0.85 | 2,710 | 2,304 | 7,204 | 4.5 K to 7.2 K (+60.30 %) |
Dec 02 2010 | JAZZ | Jazz Pharmaceutica ... | MYERS ROBERT M | President | Buy | J | 0.85 | 4,692 | 3,988 | 156,898 | 152.2 K to 156.9 K (+3.08 %) |
Dec 02 2010 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Buy | J | 0.85 | 4,594 | 3,905 | 284,775 | 280.2 K to 284.8 K (+1.64 %) |
Dec 02 2010 | JAZZ | Jazz Pharmaceutica ... | Colligan Joan | Principal Accountin ... | Buy | J | 0.85 | 2,790 | 2,372 | 14,424 | 11.6 K to 14.4 K (+23.98 %) |
Nov 19 2010 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Option Exercise | M | 1.25 | 46,663 | 58,329 | 33,337 | |
Nov 19 2010 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Sell | S | 15.05 | 46,663 | 702,278 | 105,830 | 152.5 K to 105.8 K (-30.60 %) |
Nov 19 2010 | JAZZ | Jazz Pharmaceutica ... | Wissel Janne LT | SVP, Chief Regulato ... | Buy | M | 1.25 | 46,663 | 58,329 | 152,493 | 105.8 K to 152.5 K (+44.09 %) |
Nov 19 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | M | 1.25 | 40,000 | 50,000 | 40,000 | |
Nov 19 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Sell | S | 15.13 | 16,129 | 244,032 | 4,494 | 20.6 K to 4.5 K (-78.21 %) |
Nov 19 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Sell | S | 15.75 | 40,000 | 630,000 | 20,623 | 60.6 K to 20.6 K (-65.98 %) |
Nov 19 2010 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Buy | M | 1.25 | 40,000 | 50,000 | 60,623 | 20.6 K to 60.6 K (+193.96 %) |
Sep 10 2010 | JAZZ | Jazz Pharmaceutica ... | MYERS ROBERT M | President | Buy | P | 9.76 | 6,000 | 58,560 | 152,206 | 146.2 K to 152.2 K (+4.10 %) |
Sep 01 2010 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Buy | P | 8.60 | 10,000 | 86,000 | 280,181 | 270.2 K to 280.2 K (+3.70 %) |
Sep 01 2010 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Buy | P | 8.93 | 24,311 | 217,097 | 50,000 | 25.7 K to 50 K (+94.64 %) |
Sep 01 2010 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Buy | P | 8.53 | 25,689 | 219,127 | 25,689 | 0 to 25.7 K |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | A | 0.00 | 3,197 | 0 | 7,936 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | COLELLA SAMUEL D | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 0.00 | 3,349 | 0 | 20,461 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | A | 0.00 | 3,045 | 0 | 14,453 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 0.00 | 3,045 | 0 | 8,303 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 0.00 | 3,309 | 0 | 3,309 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | TANANBAUM JAMES B | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 0.00 | 3,045 | 0 | 15,881 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | MICHELSON MICHAEL W | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | MICHELSON MICHAEL W | Director | Option Exercise | A | 0.00 | 3,045 | 0 | 18,256 | |
Aug 27 2010 | JAZZ | Jazz Pharmaceutica ... | Zilkha Nathaniel M | Director | Option Exercise | A | 8.23 | 12,500 | 102,875 | 12,500 |